September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Yüksel Ürün: Denosumab every 12 weeks vs. every 4 weeks in mCRPC
Feb 18, 2025, 15:11

Yüksel Ürün: Denosumab every 12 weeks vs. every 4 weeks in mCRPC

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on X:

“Denosumab every 12 weeks vs. every 4 weeks in mCRPC:

Lower risk of ONJ and tooth infections with q12w dosing.

Favorable long-term safety profile.

Could q12w become the new standard?”

Yüksel Ürün: Denosumab every 12 weeks vs. every 4 weeks in mCRPC

More posts featuring Yüksel Ürün.